Quarterly report pursuant to Section 13 or 15(d)

Operating Segments (Tables)

v3.20.1
Operating Segments (Tables)
3 Months Ended
Mar. 31, 2020
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information

The table below presents certain financial information of our operating segments for the three months ended March 31, 2020 and 2019 (in thousands):

 

Segment Reporting for the Quarter Ended March 31, 2020

 

    Treatment     Services     Medical     Segments Total     Corporate(1)     Consolidated Total  
Revenue from external customers   $ 9,563     $ 15,297           $ 24,860     $     $ 24,860  
Intercompany revenues     207       8             215              
Gross profit     2,745       1,895             4,640             4,640  
Research and development     94       66       66       226       6       232  
Interest income                             56       56  
Interest expense     (18 )     (6 )           (24 )     (96 )     (120 )
Interest expense-financing fees                             (68 )     (68 )
Depreciation and amortization     264       77             341       5       346  
Segment income (loss) before income taxes     1,547       1,318       (66 )     2,799       (1,477 )     1,322  
Income tax expense     (14 )                 (14 )           (14 )
Segment income (loss)     1,533       1,318       (66 )     2,785       (1,477 )     1,308  
Expenditures for segment assets     679       214             893       3       896 (2)

 

Segment Reporting for the Quarter Ended March 31, 2019

 

    Treatment     Services     Medical     Segments Total     Corporate(1)     Consolidated Total  
Revenue from external customers   $ 9,905     $ 1,803           $ 11,708     $     $ 11,708  
Intercompany revenues     2       21             23              
Gross profit/(negative) gross profit     2,957       (456 )           2,501             2,501  
Research and development     147             74       221       6       227  
Interest income                             81       81  
Interest expense     (17 )     (9 )           (26 )     (61 )     (87 )
Interest expense-financing fees                             (10 )     (10 )
Depreciation and amortization     237       78             315       8       323  
Segment income (loss) before income taxes     1,875       (1,012 )     (74 )     789       (1,300 )     (511 )
Income tax expense     (39 )                 (39 )           (39 )
Segment income (loss)     1,836       (1,012 )     (74 )     750       (1,300 )     (550 )
Expenditures for segment assets     222       2             224             224 (2)

 

(1) Amounts reflect the activity for corporate headquarters not included in the segment information.

 

(2) Net of financed amount of $82,000 and $4,000 for the three month ended March 31, 2020 and 2019, respectively.